Beyond Air Inc XAIR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XAIR is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.28
- Day Range
- $1.13–1.25
- 52-Week Range
- $1.13–6.36
- Bid/Ask
- $1.19 / $1.26
- Market Cap
- $53.93 Mil
- Volume/Avg
- 509,017 / 298,184
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 53.65
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 98
- Website
- https://www.beyondair.net
Comparables
Valuation
|
Metric
|
XAIR
|
ICVX
|
ANIK
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 2.00 | 3.30 | 1.79 |
Price/Sales | 53.65 | — | 2.28 |
Price/Cash Flow | — | — | 36.73 |
Price/Earnings
XAIR
ICVX
ANIK
Financial Strength
|
Metric
|
XAIR
|
ICVX
|
ANIK
|
|---|---|---|---|
Quick Ratio | 2.73 | 17.59 | 3.50 |
Current Ratio | 3.39 | 18.06 | 5.26 |
Interest Coverage | −36.73 | — | — |
Quick Ratio
XAIR
ICVX
ANIK
Profitability
|
Metric
|
XAIR
|
ICVX
|
ANIK
|
|---|---|---|---|
Return on Assets (Normalized) | −60.39% | −29.30% | −1.35% |
Return on Equity (Normalized) | −115.09% | −31.87% | −1.65% |
Return on Invested Capital (Normalized) | −79.62% | −34.69% | −2.24% |
Return on Assets
XAIR
ICVX
ANIK
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Sswmcmypw | Tvzzg | $185.4 Bil | |
SYK
| Stryker Corp | Vhmdczpqm | Bhrmg | $128.2 Bil | |
BSX
| Boston Scientific Corp | Rjhxhxczc | Ksyhqss | $107.7 Bil | |
MDT
| Medtronic PLC | Rpztbrhf | Sfndmpz | $105.2 Bil | |
DXCM
| DexCom Inc | Khmcvypw | Qsv | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Xgczhtdkb | Pyvsgf | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Bcdwjhwwbv | Swk | $24.6 Bil | |
ALGN
| Align Technology Inc | Yvrpkxl | Cxkjfxl | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Cpqsxklk | Brqnmbb | $19.0 Bil | |
PODD
| Insulet Corp | Ssyzhchzc | Mfcyj | $11.5 Bil |